Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

August 27, 2015 10:58 PM ET


Company Overview of GlaxoSmithKline LLC

Company Overview

GlaxoSmithKline LLC focuses on discovering, developing, and delivering medicines, vaccines, and other healthcare products for customers in the United States. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. The company also provides vaccines for children and adults; and over-the-counter products. GlaxoSmithKline LLC was formerly known as SmithKline Beecham Corporation. The company was incorporated in 1929 and is based in Philadelphia, Pennsylvania. GlaxoSmithKline LLC operates as a subsidiary of GlaxoSmith...

5 Crescent Drive

Philadelphia, PA 19112

United States

Founded in 1929





Key Executives for GlaxoSmithKline LLC

Age: 54
Compensation as of Fiscal Year 2015.

GlaxoSmithKline LLC Key Developments

GlaxoSmithKline LLC Wins $13 Million Federal Contract

GlaxoSmithKline LLC won a $13,000,127 federal contract from the U.S. Department of Health and Human Services' Office of the Secretary for the advanced research and development of chemical, biological, radiological and nuclear medical countermeasures for the Biomedical Advanced Research and Development Authority.

GlaxoSmithKline LLC Presents at EBD Group's Biopharm America 2014 Conference, Sep-22-2014 09:00 AM

GlaxoSmithKline LLC Presents at EBD Group's Biopharm America 2014 Conference, Sep-22-2014 09:00 AM. Venue: Boston Marriott Copley Place, 110 Huntington Avenue, Boston, MA 02116, United States. Speakers: Katy Moore, Senior Director, Scientific Licensing, Worldwide Business Development.

North Carolina Court Denies Motion to Dismiss, Brought by GlaxoSmithKline LLC

Genetic Technologies Limited announced that the United States District Court for the Middle District of North Carolina issued an Order denying a motion brought by GlaxoSmithKline LLC (GSK) to dismiss the patent infringement lawsuit brought against it by GTG. This action was initially brought by GTG against GSK in 2011, in the District Court of Colorado, but was then moved at the request of GSK to the District Court for the Middle District of North Carolina. Thereafter, both sides filed motions in support of their different legal perspectives. Most recently on June 27, 2014, GSK moved to have GTG’s Second Amended Complaint dismissed, arguing the relevant GTG patent covers natural phenomena or laws of nature that are not entitled to patent protection, and that the Court should therefore dismiss the action. On August 22, 2014, the Court issued an Order denying GSK’s motion to dismiss.

Similar Private Companies By Industry

Company Name Region
Spring Bank Pharmaceuticals, Inc. United States
Neotropix, Inc. United States
Sciegen Pharmaceuticals, Inc. United States
VGX Pharmaceuticals, LLC United States
Pharmasol Corporation United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GlaxoSmithKline LLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at